Literature DB >> 25228209

Is there an end in sight for encapsulating peritoneal sclerosis?

Klara Paudel1, Stanley L Fan2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25228209      PMCID： PMC4164398          DOI： 10.3747/pdi.2014.00087

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN： 0896-8608            Impact factor:   1.756


× No keyword cloud information.
  15 in total

1.  The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis.

Authors:  Gowrie Balasubramaniam; Edwina A Brown; Andrew Davenport; Hugh Cairns; Barbara Cooper; Stanley L S Fan; Ken Farrington; Hugh Gallagher; Patrick Harnett; Sally Krausze; Simon Steddon
Journal:  Nephrol Dial Transplant       Date:  2009-02-11       Impact factor: 5.992

2.  Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: position paper for ISPD.

Authors:  Edwina A Brown; Wim Van Biesen; Fredric O Finkelstein; Helen Hurst; David W Johnson; Hideki Kawanishi; Roberto Pecoits-Filho; Graham Woodrow
Journal:  Perit Dial Int       Date:  2009 Nov-Dec       Impact factor: 1.756

3.  Successful surgical management of encapsulating peritoneal sclerosis.

Authors:  Hideki Kawanishi; Hiroshi Watanabe; Misaki Moriishi; Shinichiro Tsuchiya
Journal:  Perit Dial Int       Date:  2005-04       Impact factor: 1.756

4.  Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival.

Authors:  Mark Lambie; James Chess; Kieron L Donovan; Yong Lim Kim; Jun Young Do; Hi Bahl Lee; Hyunjin Noh; Paul F Williams; Andrew J Williams; Sara Davison; Marc Dorval; Angela Summers; John D Williams; John Bankart; Simon J Davies; Nicholas Topley
Journal:  J Am Soc Nephrol       Date:  2013-09-05       Impact factor: 10.121

5.  Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation.

Authors:  Anabela S Rodrigues; Manuela Almeida; Isabel Fonseca; Margarida Martins; Maria J Carvalho; Fernanda Silva; Carlos Correia; Mário J Santos; António Cabrita
Journal:  Nephrol Dial Transplant       Date:  2005-12-06       Impact factor: 5.992

6.  Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study.

Authors:  Mario R Korte; Marien W Fieren; Denise E Sampimon; Hester F Lingsma; Willem Weimar; Michiel G H Betjes
Journal:  Nephrol Dial Transplant       Date:  2010-06-27       Impact factor: 5.992

7.  Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes.

Authors:  David W Johnson; Yeoungjee Cho; Brian E R Livingston; Carmel M Hawley; Stephen P McDonald; Fiona G Brown; Johan B Rosman; Kym M Bannister; Kathryn J Wiggins
Journal:  Kidney Int       Date:  2010-03-10       Impact factor: 10.612

8.  Dialysate cytokine levels do not predict encapsulating peritoneal sclerosis.

Authors:  Catriona Goodlad; Frederick W K Tam; Sohail Ahmad; Gurjeet Bhangal; Bernard V North; Edwina A Brown
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

9.  Encapsulating peritoneal sclerosis in the new millennium: a national cohort study.

Authors:  Michaela C Brown; Keith Simpson; Jan J Kerssens; Robert A Mactier
Journal:  Clin J Am Soc Nephrol       Date:  2009-06-18       Impact factor: 8.237

10.  Tamoxifen ameliorates peritoneal membrane damage by blocking mesothelial to mesenchymal transition in peritoneal dialysis.

Authors:  Jesús Loureiro; Pilar Sandoval; Gloria del Peso; Guadalupe Gónzalez-Mateo; Vanessa Fernández-Millara; Beatríz Santamaria; Maria Auxiliadora Bajo; José Antonio Sánchez-Tomero; Gonzalo Guerra-Azcona; Rafael Selgas; Manuel López-Cabrera; Abelardo I Aguilera
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.